PMID: 216019Dec 1, 1978Paper

Biochemical evidence for presynaptic and postsynaptic alpha-adrenoceptors in rat heart membranes: positive homotropic cooperativity of presynaptic binding

Proceedings of the National Academy of Sciences of the United States of America
P GuicheneyP Meyer


In crude rat cardiac membrane preparations, [3H]dihydroergocryptine (3H-DHE) appears to bind to two classes of sites with limited capacity, differing in their specificities and their affinities. The first class of binding sites interacts preferentially with the postsynaptic alpha-adrenoceptor blocker ARC239, as can be expected for postsynaptic alpha-adrenoceptors. The binding of 3H-DHE to these receptors follows the law of mass action, with a high affinity for 3H-DHE (Kd 25 degrees C = 1.67 +/- 0.37 nM). Postsynaptic saturating levels of 3H-DHE are necessary to occupy the second class of binding sites. These sites exhibit a preferential affinity for presynaptic ligands such as clonidine and yohimbine, as would be expected for presynaptic alpha-adrenergic receptors. This presynaptic binding shows a markedly positive homotropic cooperativity (Hill n = 2.88) with initial and final apparent Kds of 23 and 0.83 nM, respectively. Free energy of interaction between sites is of the order of 2 kcal (8.36 kJ)/mol of sites. These characteristics provide a rational molecular basis for the functional role of presynaptic alpha-adrenoceptors that mediate the inhibition of norepinephrine release from nerve endings.


Sep 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·M TittlerP Seeman

❮ Previous
Next ❯


Sep 1, 1979·Naunyn-Schmiedeberg's Archives of Pharmacology·H J Schümann, O E Brodde
May 1, 1980·Naunyn-Schmiedeberg's Archives of Pharmacology·P J MiachP Meyer
Sep 1, 1986·Cellular and Molecular Neurobiology·A HirataN Akaike
Oct 29, 1985·European Journal of Pharmacology·J P Maltier, C Legrand
Jan 1, 1981·Comparative Biochemistry and Physiology. C: Comparative Pharmacology·G Stene-Larsen
Feb 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·D Atlas, M Adler
Jan 1, 1988·Clinical and Experimental Pharmacology & Physiology·A De Luca, M J Rand
Sep 1, 1981·Molecular and Cellular Endocrinology·J H Exton
Oct 29, 1984·Life Sciences·M SandriniM Baraldi
Nov 29, 1982·Life Sciences·J S PartillaG S Roth
Jul 16, 1985·Biochemical and Biophysical Research Communications·R K Jaiswal, R K Sharma
Jan 1, 1984·Annals of the New York Academy of Sciences·L H Opie, F T Thandroyen
Jul 1, 1980·Journal of Neurochemistry·S H Snyder, R R Goodman
Jun 15, 1984·Biochemical Pharmacology·T SkomedalJ B Osnes
Sep 1, 1980·Acta Pharmacologica Et Toxicologica·T SkomedalI Oye
Jan 1, 1983·British Journal of Clinical Pharmacology·D P NichollsR G Shanks
Jan 1, 1980·British Journal of Pharmacology·G KunosS O'Regan
Aug 1, 1981·Circulation Research·D CousineauC A Goresky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.